Jie He
Chinese Academy of Medical Sciences & Peking Union Medical College · 853 works · 54,591 citations · h-index 89
Top works
- Cancer statistics in China, 2015
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- [Report of cancer epidemiology in China, 2015].
- Cancer incidence and mortality in China, 2022
- Cancer incidence and mortality in China, 2016
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC
- Cancer registration in China and its role in cancer prevention and control
- Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
- Cancer incidence and mortality in China, 2015
- Perioperative Nivolumab in Resectable Lung Cancer
- Annual report on status of cancer in China, 2011.
- Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma
- Cancer incidence and mortality in China, 2013
- [Trend analysis and projection of cancer incidence in China between 1989 and 2008].
- Epidemiology of Lung Cancer
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- [Trend analysis of cancer mortality in China between 1989 and 2008].
- Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
- LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma